Apr 22 |
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
|
Mar 27 |
Spruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should Know
|
Mar 23 |
Revenue Downgrade: Here's What Analysts Forecast For Spruce Biosciences, Inc. (NASDAQ:SPRB)
|
Mar 21 |
Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why
|
Mar 16 |
Spruce Biosciences, Inc. (NASDAQ:SPRB) Just Reported Earnings, And Analysts Cut Their Target Price
|
Mar 13 |
Spruce Biosciences stock craters 75% on failed Phase 2 study
|
Mar 13 |
Spruce Biosciences Inc (SPRB) Reports Full Year 2023 Financial Results Amid Clinical Trial Setbacks
|
Mar 13 |
Spruce Biosciences reports FY results
|
Mar 13 |
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
|
Mar 13 |
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
|